FRAMINGHAM, Mass., Nov. 1 /PRNewswire-FirstCall/ -- StatSure Diagnostics Systems, Inc. , announced that Steve Peltzman, Chairman and Chief Executive Officer will make a company presentation at the Rodman & Renshaw 8th Annual Healthcare Conference in New York. The conference is being held November 6-8, 2006, at the New York Palace Hotel. Mr. Steve Peltzman will present the StatSure story on November 8, at 2:50 pm. The presentation will be web cast at http://www.shareholder.com/ntii/medialist.cfm
About StatSure Diagnostic Systems, Inc.
StatSure Diagnostic Systems is engaged in the development, manufacture and marketing of rapid immunoassay tests for the detection of sexually transmitted and other infectious diseases; in addition, the Company has developed and is marketing a product line of patented, oral-fluid collection devices. StatSure’s proprietary platforms provide significant customer benefits and competitive advantages as compared to similar products that are currently available. Improved accuracy, operator convenience, and reduced risk of infection from collecting and handling specimens, have been engineered into SDS products. All of our diagnostic tests are based on the same easy-to-use technology platform, thus facilitating the development of future products. StatSure Diagnostic System’s technology provides a quick, accurate, portable, safe and cost-effective solution.
StatSure Diagnostics Systems, Inc.
CONTACT: Jenny Hoefel for StatSure Diagnostic Systems, Inc., +1-617-227-0012 ext.233, jhoefel@thecastlegrp.com
